- |||||||||| Trial completion, Trial primary completion date: NCCLS Interpretive Criteria for Salmonella (clinicaltrials.gov) - Jun 26, 2017
P=N/A, N=50, Completed, Enrolling by invitation --> Completed | Trial primary completion date: Dec 2016 --> Jun 2017
- |||||||||| Enrollment open: NCCLS Interpretive Criteria for Salmonella (clinicaltrials.gov) - Dec 18, 2015
P=N/A, N=50, Enrolling by invitation, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 Active, not recruiting --> Enrolling by invitation
- |||||||||| Gatiflox (gatifloxacin) / Orient Europharma
Enrollment closed, Head-to-Head: Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever (clinicaltrials.gov) - Jul 16, 2014 P4, N=300, Active, not recruiting, Not yet recruiting --> Recruiting | Initiation date: Apr 2014 --> Jul 2014 Recruiting --> Active, not recruiting
- |||||||||| Enrollment closed: NCCLS Interpretive Criteria for Salmonella (clinicaltrials.gov) - Aug 22, 2012
P=N/A, N=50, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
|